NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis

Effect of Pneumatic Tube System Transport on Cell-Free DNA.

Author(s): Geerlings MJ, Hofste LSM, Kamping EJ, Abdi Z, Tolmeijer SH, Garms LM, Klarenbeek BR, Ligtenberg MJL

Publication: Clin Chem, 2021, Vol. 67, Page 434-435

PubMed ID: 33280007 PubMed Review Paper? No

Purpose of Paper

This paper compared two transportation methods (courier, pneumatic tube system (PTS)) regarding potential differences in the number of detectable copies of three different DNA amplicons in blood collected in Roche cell-free DNA tubes and EDTA tubes.

Conclusion of Paper

Transportation of EDTA blood by PTS resulted in more copies of all three-sized DNA amplicons in plasma compared to when transported by by courier; however, transportation method of blood collected in Roche cell-free DNA tubes did not affect copy numbers of differently sized DNA amplicons. The authors conclude that DNA is released from blood cells in EDTA tubes, but not Roche cell-free DNA tubes, during PTS transport.

Studies

  1. Study Purpose

    This study compared two transportation methods (courier, PTS) regarding potential differences in the number of detectable copies of three different DNA amplicons in blood collected in Roche cell-free DNA tubes and EDTA tubes.  Blood was collected from a total of 25 patients with esophageal cancer into either duplicate EDTA tubes (8 patients) or Roche cell-free DNA blood collection tubes (17 patients). One specimen from each set was transported by PTS (840 m at 3.5-4.0 m/sec) and the other was transported by courier. Plasma was obtained by centrifugation at 1600 x g for 10 min followed by 16,000 x g for 10 min within 4 h (EDTA tubes) or 4 days (Roche cell-free DNA tubes) of collection. Plasma was stored at -80°C until DNA isolation using the QiaAmp Circulating Nucleic Acid Kit. DNA was quantified using a multiplex ddPCR assay that amplified 137, 420, and 1950 bp fragments of β-Actin.

    Summary of Findings:

    Transportation of EDTA blood by PTS resulted in more copies of the 137, 420 and 1950 bp βActin amplicons in plasma compared to case-matched specimens transported by courier (+53%, P=0.002; +59%, P=0.004; and +111%, P=0.001, respectively). In contrast, transportation method of blood in Roche cell-free DNA tubes did not significantly affect copy numbers of the 137, 420 and 1950 bp amplicons (+3%, +3%, and +15%, respectively). The authors conclude that DNA is released from blood cells in EDTA tubes but not Roche cell-free DNA tubes during PTS transport.

    Biospecimens
    Preservative Types
    • Other Preservative
    • Frozen
    Diagnoses:
    • Neoplastic - Carcinoma
    Platform:
    AnalyteTechnology Platform
    DNA Digital PCR
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Storage Within hospital transportation method Pneumatic tube system
    Hand-delivered
    Digital PCR Specific Targeted nucleic acid β-actin
    Digital PCR Specific Length of gene fragment 137 bp
    420 bp
    1950 bp
    Biospecimen Acquisition Type of collection container/solution EDTA tube
    Roche cell-free DNA tubes

You Recently Viewed  

News and Announcements

  • Most Downloaded SOPs in 2024

  • New Articles on the GTEx Project are Now FREELY Available!

  • Just Published!

  • More...